Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

CRMDCRMD
Showing 8 of 15 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in CORMEDIX INC

Yes. Goldman Sachs holds 466,393 shares of CRMD (Cormedix), worth $3.7M, as of its Q2 2026 13F filing. It reduced the position by 44,936 shares (-8.8%) from Q1 2026. Goldman Sachs has held CRMD since Q2 2023, across 13 quarterly 13F filings.

Current Value

$3.7M

Current Shares

466,393

Total Value Change

+$2.6M

Total Shares Change

+331,005

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
466,393
-8.8%
$3.7M0.0%$7.85
0
2026-Q1
Decreased
511,329
-38.3%
$3.5M0.0%$6.79
0
2025-Q4
Increased
828,781
+259.1%
$9.6M0.0%$11.63
45
2025-Q3
Increased
230,810
+17.4%
$2.7M0.0%$11.63
31
2025-Q2
Increased
196,601
+9.3%
$2.4M0.0%$12.32
29
2025-Q1
Decreased
179,798
-9.6%
$1.1M0.0%$6.16
0
2024-Q4
Increased
198,920
+46.9%
$1.6M0.0%$8.10
35
2024-Q3
Increased
135,388
+91.3%
$1.1M0.0%$8.08
40

Other major holders of CRMD: BlackRock, Inc., VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used